Literature DB >> 32851372

Sarcoidosis in Jordan: A Study of the Clinical Phenotype and Disease Outcome.

Fatima Alnaimat1, Khaled Al Oweidat2, Anas Alrwashdeh3, Ahmad Alnashrati3, Saba Barham3, Mohammad Hijaz3, Dina Murad3, Sameeha Alshelleh4, Nathir Obeidat2.   

Abstract

OBJECTIVES: This study aims to evaluate the clinical phenotypic features of sarcoidosis in a single-center academic hospital in Jordan. PATIENTS AND METHODS: A retrospective file review was performed at an academic medical center in Jordan that included all patients diagnosed with sarcoidosis between January 2000 and December 2018. A total of 150 patients with sarcoidosis (38 males, 112 females; mean age 47.8±11.7 years; range, 17 to 79 years) were evaluated. Clinical data extracted from the files included the sex of the patient, the age at time of diagnosis, diagnosis date, the season during which the diagnosis was established, and smoking history. Biopsy histopathology, spirometry, nerve conduction, echocardiography, and imaging reports including plain radiographs, ultrasonographic, magnetic resonance and computed tomography reports were reviewed. Data including laboratory values, medication usage, clinical outcomes, and morbidity/mortality were collected. Pulmonary function tests including spirometry and lung volumes along with the diffusing capacity for carbon monoxide were reviewed for the presence of restriction, obstruction or reduction in the diffusion capacity of carbon monoxide. Identification of extra-thoracic organ involvement was determined in each patient in accordance with the criteria suggested by the updated World Association of Sarcoidosis and Other Granulomatous Disorders.
RESULTS: A total of 77.3% of the patients were diagnosed by biopsy. One case of Lofgren's syndrome was identified. Of the patients, 18.0% had isolated pulmonary sarcoidosis, 75.3% had pulmonary and extra-pulmonary sarcoidosis and 6.7% had isolated extra-pulmonary sarcoidosis while 81.3% had respiratory symptoms, mostly shortness of breath and cough. Extra-thoracic organ involvement mostly involved the musculoskeletal system (33%) followed by the skin (20%). Female patients had more extra-thoracic involvement but the sex difference was only statistically significant for cutaneous involvement. Of the patients, 84% received treatment while 20% had disease remission during the first two years after diagnosis and 70% required treatment beyond two years after diagnosis.
CONCLUSION: Various sarcoidosis clinical phenotypes are seen among Jordanian patients. Jordanian females are more affected by the disease and have more extra-thoracic involvement compared to male patients. A large number of the study patients received treatment.
Copyright © 2020, Turkish League Against Rheumatism.

Entities:  

Keywords:  Arab; Jordan; World Association of Sarcoidosis and Other Granulomatous Disorders; sarcoidosis

Year:  2020        PMID: 32851372      PMCID: PMC7406155          DOI: 10.46497/ArchRheumatol.2020.7584

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  30 in total

1.  Clinical presentation of sarcoidosis in a mixed population in the middle east.

Authors:  N Behbehani; B JayKrishnan; M Khadadah; H Hawa; Y Farah
Journal:  Respir Med       Date:  2007-08-13       Impact factor: 3.415

Review 2.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

3.  Sarcoidosis in Israel: Clinical Outcome Status, Organ Involvement, and Long-Term Follow-Up.

Authors:  Natalia Markevitz; Gali Epstein Shochet; Yair Levi; Lilach Israeli-Shani; David Shitrit
Journal:  Lung       Date:  2017-05-15       Impact factor: 2.584

4.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.

Authors:  E Neville; A N Walker; D G James
Journal:  Q J Med       Date:  1983

5.  Simple rule for calculating normal erythrocyte sedimentation rate.

Authors:  A Miller; M Green; D Robinson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

6.  Clinical features of Sarcoidosis in Oman: A report from the Middle East region.

Authors:  B Jayakrishnan; Nasser Al-Busaidi; Ahsan Al-Lawati; Jojy George; Omar A Al-Rawas; Yaqoub Al-Mahrouqi; Nabil Al-Lawati
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2016-10-07       Impact factor: 0.670

7.  Fine-mapping in African-American women confirms the importance of the 10p12 locus to sarcoidosis.

Authors:  Y C Cozier; E A Ruiz-Narvaez; C J McKinnon; J S Berman; L Rosenberg; J R Palmer
Journal:  Genes Immun       Date:  2012-09-13       Impact factor: 2.676

8.  Sarcoidosis in the eastern region of Saudi Arabia.

Authors:  Thamer H Al-Khouzaie; Jaffar A Al-Tawfiq; Faisal M Al Subhi
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

9.  Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis.

Authors:  Esam H Alhamad; Mohammed O Alanezi; Majdy M Idrees; Mohammad K Chaudhry; Ali M AlShahrani; Arthur Isnani; Shaffi Shaikh
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

10.  Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Authors:  Natalie Ertz-Archambault; Heidi Kosiorek; Gretchen E Taylor; Katalin Kelemen; Amylou Dueck; Janna Castro; Robert Marino; Susanne Gauthier; Laura Finn; Lisa Z Sproat; Jeanne Palmer; Ruben A Mesa; Aref Al-Kali; James Foran; Raoul Tibes
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.